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Background: Exacerbations are key events in Chronic Obstructive Pulmonary Disease (COPD), 
affecting lung function decline and quality of life. The effect of exposure to different air pollutants 
on COPD exacerbations is not clear. 
Objective: To carry out a systematic review examining associations between air pollutants and 
hospital admissions for COPD exacerbations. 
Data sources: MEDLINE, EMBASE, BIOSIS & Science Citation Index, and the Air Pollution 
Epidemiology Database were searched from 1980 until September 2015.  
Data extraction: Inclusion criteria focused on studies presenting solely a COPD outcome defined 
by hospital admissions, and a measure of gaseous air pollutants and particle fractions. The 
association between each pollutant with COPD admissions was investigated in meta-analyses 
using random-effects models. Analyses were stratified by geographical clusters to investigate the 
consistency of the evidence worldwide.  
Synthesis: 46 studies were included and results for all the pollutants under investigation showed 
marginal positive associations; however the number of included studies was small with high 
heterogeneity between them and there was evidence of small-study bias. Geographical clustering 
of the effects of pollution on COPD hospital admissions was evident and reduced heterogeneity 
significantly.  
Conclusions: The most consistent associations was between a 1mg/m3 increase in carbon 
monoxide levels with COPD related admissions; Odds Ratio: 1.02 (95%CI: 1.01-1.03). The 
heterogeneity was moderate and there was a consistent positive association in both Europe and 
North America, although levels were clearly below WHO guideline values.   
There is mixed evidence on the effects of environmental pollution on COPD exacerbations. 
Limitations of previous studies included the low spatio-temporal resolution of pollutants, 
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inadequate control for confounding factors, and the use of aggregated health data that ignore 
personal characteristics. The need for more targeted exposure estimates in a large number of 
geographical locations is evident.   
Funding: This research was funded by the Medical Research Council (MR/L019744/1). 
 























Intense energy consumption together with industrial and transportation emissions, have led to 
population exposure to a diverse variety of unhealthy concentrations of air pollution, leading to 
increased morbidity and mortality primarily due to cardiovascular and respiratory causes (1).  
 
Vulnerable groups include patients with chronic obstructive pulmonary disease (COPD), which is 
currently the fourth leading cause of death worldwide (2). Total deaths from COPD are predicted 
to increase by more than 30% in the next ten years and economic costs for the management of 
COPD are estimated at $36 billion annually in the United States (3). Although smoking is the 
most important cause of COPD, a substantial proportion of cases cannot be explained by this 
lifestyle factor alone (4).  
 
Exacerbations of COPD are a common cause of adult emergency hospital admissions and are 
associated with increased mortality and decreased quality of life. Patients may experience at least 
one exacerbation per year, (5) and as the disease worsens, exacerbations become more frequent 
and severe (6). The effect of environmental exposure on COPD exacerbations is not clear. A 
number of variables may trigger COPD exacerbations (7), and understanding and addressing the 
effects of air quality may be key in managing COPD exacerbations. From a policy perspective, 
detecting air pollution-induced health effects early can lead to more effective control of exposures 
and more appropriate interventions.  
 
The present review evaluates the strength and consistency of current literature documenting the 
effect of different air pollutants on hospital admissions for COPD exacerbations. Previous meta-
analytic studies on the effects of air pollution on COPD-related hospital admissions and mortality 
have focused on the effects of particles (8–11) or the effects of gases such as ozone and nitrogen 
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dioxide (12,13). This review is unique in that it simultaneously assesses the effects of key 
atmospheric pollutants, including gases and particulate matter, on hospital admissions for patients 




To assess the effects of air pollutants on COPD hospital admissions by reviewing the literature 
from time-series and case-crossover studies. 
 
Search strategy 
Two conceptual terms were developed for the search strategy: “Environmental factors” and 
“health outcomes” relating to COPD. Search terms were developed using combinations of 
controlled vocabulary and free-text terms. Only papers with title, keywords or abstracts including 
records from the search categories were included. Search terms from these categories were 
combined using the AND Boolean logic operator. “Environmental factors” refers to air pollution, 
including gases and particles suspected of affecting human health such as carbon monoxide (CO), 
nitrogen dioxide (NO2), sulphur dioxide (SO2), ozone (O3), and particulates with a diameter of 
less than 10 and 2.5 micrometres in diameter (PM10 and PM2.5 respectively). The primary “health 
outcome” of interest in this review is COPD exacerbation qualified by hospital admissions.  
 
Searches were conducted through MEDLINE, MEDLINE In-Process & Other Non-Indexed 
Citations, EMBASE, BIOSIS & Science Citation Index from 1980 until September 2015 using 
PRISMA and MOOSE guidelines (14). We accessed the grey literature to address potential 
publication bias and searched additional sources including reports from the World Health 
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Organisation (WHO), the Committee on the Medical Effects of Air Pollution (COMEAP), and the 
Air Pollution Epidemiology Database (APED) from St George’s University. The search strategy is 
included in the supplementary materials (SM). 
 
Inclusion and exclusion criteria 
Based on the above, inclusion and exclusion criteria (Table 1) were applied to titles, keywords 
and abstracts, before obtaining full reports on the studies that appeared to meet the criteria.  
 
Classification and quality assurance 
Two authors independently reviewed titles and abstracts for relevance and assessed whether 
they were related to the scope of this study. Relevant papers were included for full text review, 
and tested against the inclusion/exclusion criteria. The methodological quality of the studies was 
assessed based on population size, study duration and design, air pollutant exposure measurement, 
diagnosis of COPD, potential confounding factors, controls used, statistical methods, and length 
of follow up. A descriptive summary of the studies is included in Table 2 (SM). 
 
Risk of bias assessment 
A risk of bias assessment was devised based upon the Newcastle-Ottowa scale (15) and 
assessment domains included the representativeness of exposure, ascertainment of exposure, 
comparability i.e. controlling for confounders, and reporting of missing data (Figure 8).  
 
Small study bias was assessed using the “trim and fill” method (16) (Figure 9 SM). The 
percentage of variation between studies due to heterogeneity was assessed with Galbraith (radial) 
plots (Figure 10 SM) and quantified with Cochran’s Q measure in random effects models. The I2 
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statistic was calculated as the weighted sum of squared differences between individual study 
effects and the pooled effect across studies as follows:  
I² = 100% x (Q-degrees of freedom)/Q.       
 
Data extraction and synthesis of evidence 
Full text relevant studies were coded accordingly to address the topic focus of the review: 
study type (e.g. primary research, meta-analysis), focus of the study (e.g. health outcomes), 
country in which the research was conducted, duration of the study, and methodology employed 
(e.g. epidemiological study). Estimates of effects extracted from included studies were presented 
as odds ratios (OR), relative risks (RR) or percentage change (PC) in COPD hospital admissions. 
(See supplementary material for details).  
 
Results 
Methodological classification of studies 
Among the 46 studies included in the meta-analysis, 15 were performed in North America and 
19 in Europe. Eight studies were conducted in Asia, while limited information was available from 
South America and Australia. Therefore, three geographical clusters were defined based on 
available evidence from the literature.  
 
Two methodological approaches were identified: time-series and case-crossover studies. The 
most common approach was ecological time-series investigations, where aggregated health 
outcomes of the total population were associated with daily variations in air pollutants after 
controlling for confounding factors, such as temperature or influenza epidemics. That approach 
has the potential for including a large number of days over several years for a large population 
     
   
   
   
   
   
    
     
    
   






with advantages of improving the precision of estimate of effect of the exposure-response 
relationships. The vast majority of these studies analysed exposure-response relationships at 
single city level, with only six time-series multicity investigations (17–22). 
 
Case-crossover studies measured COPD exacerbations in cohorts of COPD patients. 
Conceptually, case-crossover design is different from time-series as the unit of assessment is at 
the individual level, where each patient acts as their own control accounting for variation at the 
individual level. A total of 11 studies with a case-crossover design were included in the meta-
analysis. The study population in those studies was relatively small compared with the time-series 
investigations, which would result in a smaller precision of the estimate. Only one case crossover 
study (23) was organised as a multicity study in 36 cities. 
 
Air pollution exposure in all time-series and case-crossover studies used measurements from 
the nearest fixed air quality monitoring station. The number of fixed monitoring stations 
employed in each study was not always reported; but ranged from a single monitoring station up 
to 31 (24). The time-resolution of the measurements was most often 24-hour average values for 
meteorological parameters and particles, and 1-hour to 8-hour maximum levels for gaseous 
pollutants.  
 
Meta-analysis of studies using single-pollutant models  
Figures 2 to 7 show forest plots for the converted odds ratios of COPD hospital admissions for 






Effect of PM10 
The pooled estimates of a total of 31 studies included in the meta-analysis for PM10 showed a 
marginal effect of a 10 μg/m3 increase of PM10 on COPD hospital admissions (Figure 2) with very 
high heterogeneity (I2=79.4 %) between studies. Out of these, 23 were ecological time series, 
while the rest were organised as case-crossover investigations. While 28 estimated a positive 
association between COPD-related hospital admissions and PM10 exposure, only 15 found that the 
association was significant.  
 
Most of the studies were conducted in Europe and North America, where a marginal effect was 
estimated (OR: 1.01, 95%CI: 1.00-1.01 for Europe and 1.00, 95% CI: 1.00–1.01 for America 
respectively), while a stronger effect was reported for studies conducted in Asia (OR: 1.02, 
95%CI: 1.01-1.03). The stronger effect reported in Asian studies might be explained by the 
approximately three-fold higher mean pollution levels of 99.8 μg/m3 ± 48.4 compared with 30.7 
μg/m3 ± 2.6 and 31.1 μg/m3 ± 3.0 for North America and Europe respectively, which were lower 
than the annual mean WHO guideline values. The meta-regression model also indicates a non-
linear relationship with stronger effects reported at higher ambient concentrations (Figure 11 SM). 
The heterogeneity among European studies (I2= 1.93%) was significantly lower than in the other 
two subgroups. The “trim and fill” method identified evidence of small-study bias on the effect 
estimates of PM10. Contrary to single-city studies, three multicity studies, one in Europe (25) and 
two in North America (20,21) did not find a significant association, while a case-crossover (23) 
and a time-series (22) study in ten US cities found a marginal association between PM10 and 
COPD hospital admissions.  
 
There is insufficient evidence to assess the lagged effects of particle exposure on COPD 
morbidity, as most studies did not specify the temporal lags of the dependent variables in the 
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regression. A further limitation includes the low temporal resolution of collected PM10 data, which 
was in most studies the daily average.  
 
Effect of PM2.5 
Due to the lack of available outdoor measurements for PM2.5 or smaller particles, evidence 
available on their potential association with COPD morbidity is limited and the heterogeneity of 
the pooled meta-analysis was high (I2 = 89.9 %). Out of the 12 studies included in the meta-
analysis (Figure 3), ten studies found a positive association; however only four found that the 
association was significant. Studies that collected measurements for both PM2·5 and PM10 
fractions found similar associations between COPD hospital admissions and these fractions 
(21,22,26–31), but overall a stronger association was found with PM2.5 (OR: 1.03, 95%CI: 1.01-
1.05) compared with PM10, which might be explained by the fact that smaller particles may 
penetrate deeper into the lungs. 
 
Similarly with PM10, the majority of studies were performed as time-series investigations, and 
most of the evidence comes from North America. When the effect estimates in the European and 
North American results were pooled, the heterogeneity was significantly reduced (I2<50%). The 
effect of PM2.5 was stronger in Asia (OR: 1.04, 95% CI: 1.00-1.08) but there was large 
heterogeneity. Highest concentration levels of PM2.5 of 41.2 μg/m3 ± 2.7, were reported in Asia 
(where the effect was stronger and significant), twice as high as in Europe (23.4 μg/m3 ± 5.3) and 
four times higher than in North America (11.3 μg/m3 ± 3.3), where the effects were lower and 
non-significant and levels were below annual mean WHO guideline values. The meta-regression 
model also pointed towards a non-linear relationship between COPD hospital admissions and 
ambient pollution levels, as there was a higher effect at higher concentrations (Figure 12 SM).  
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Although there appears to be a relationship between PM2.5 and COPD hospital admissions, 
results should be interpreted with caution due to the limited number of included studies. The “trim 
and fill” method did not detect any small-city bias. Two studies were organised as multicity 
investigations, one in 202 US cities (18) and one in seven Canadian cities (21), and reported a 
non-significant association between PM2.5 exposure and COPD exacerbations.  
 
As in the case of PM10, limited information exists on seasonal effects of fine particles on health 
outcomes with only one study in a tropical climate estimating larger effects in the cool season 
(32). Limited evidence is available on the lagged effects of PM2.5 exposure on COPD morbidity 
and points towards a shorter temporal lag than PM10 of up to two days (30). 
 
Effect of CO 
Pooled results of 15 studies for CO (Figure 4) showed a small but significant effect of a 1 
mg/m3 increase in CO on COPD admissions (OR: 1.02, 95% CI: 1.01-1.03) with moderate 
heterogeneity (I2 = 50.73%) between studies. We excluded one study in Asia from the pooled 
estimate (33) that increased the heterogeneity significantly (I2=83.6%). The re-scaled ORs for this 
study were 1.67 (95% CI 1.37, 2.04) in the warm season and 2.70 (95% CI 2.04, 3.58) in the cool 
season. Apart from two European case-crossover studies (21,30) that found a strong positive 
association, all included studies were time-series investigations. There was some evidence of 
small-study bias in the trim and fill funnel plot, supported by the non-significant negative 
association estimated by the only multicity investigation from seven Canadian cities (21). 
 
There is insufficient evidence on the association between COPD hospital admissions and CO 
exposure in geographical locations other than Europe (6 studies) and North America (7 studies). 
The heterogeneity between studies was significantly reduced in both these geographical 
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subgroups. Studies in Europe estimated overall stronger association of OR: 1.04 (95% CI: 1.02-
1.06) (I2 =47.3%) than in North America OR: 1.02 (1.01–1.03) (I2=37.5%), possibly because CO 
concentrations in Europe were higher (2.1 mg/m3 ± 0.7) compared with North America (1.5 
mg/m3 ± 0.2) and the meta-regression indicated that there is a non-linear association between 
effect and ambient concentrations (Figure 13 SM).  
Most studies found significant associations with acute (25,34) or lagged effects of up to three days 
(21,30,31,35). 
 
Effect of SO2 
The overall pooled estimate of SO2 exposure indicated a borderline effect with COPD 
admissions with moderate heterogeneity between studies (I2 = 50.8%). Out of the 23 studies 
included in the meta-analysis, 18 employed a time-series methodology. There was evidence of 
small-study bias (Figure 9).  
 
Most of the studies were performed in Europe with small heterogeneity (I2= 6.72%) between 
studies. The effects were clustered in geographical locations with a stronger positive effect 
estimate in Asia (OR: 1.03, 95% CI: 1.00-1.06) compared with the effects in North America, 
where studies failed to detect a significant association, and only a borderline effect in Europe. SO2 
levels in North America and Europe were similar with small SE (18.1 μg/m3 ± 4.7 and 18.0 μg/m3 
±3.2) while levels in Asia were higher with large SE (25.1 μg/m3 ± 11.30). The meta-regression 
model approximated a linear relationship between effect size and pollution levels (Figure 14 SM).  
 
Apart from the spatial variation of the effect of SO2, a seasonal effect might also underpin the 
estimated association. Two studies in a tropical climate in Taiwan (33,36) found a significant 
association between SO2 and COPD hospital admissions only in the cool season (Temp <25ᵒC). A 
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possible explanation might be increased coal burning for heating during the cool season in 
developing countries where levels were higher. However seasonal differences were estimated in a 
five year European study (37) with a very small but insignificant association observed in winter 
but no relationship in the summer. Most studies estimated acute effects for SO2 (21,34) or two-day 
lagged effects (21,30,38). Only one study (35) estimated longer lagged effects of up to 13 days. 
 
Effect of NO2 
Results for NO2 (Figure 6) showed an association (OR: 1.03, 95% CI: 1.02-1.05) between a 
10µg/m3 increase in NO2 and COPD admissions with high heterogeneity (I2=91.5%). We found 
evidence of small-study bias in single-city studies (Figure 9). A positive association was reported 
in 25 out of 27 studies, and a significant one in 11 studies. Only one multicity study in North 
America (21) and one in Europe (39) reported a negative non-significant effect.  
 
The majority of evidence comes from Europe, where the heterogeneity between studies was 
moderate (I2=55%). The estimated effects in Europe and North America were similar (OR: 1.01, 
95% CI: 1.00-1.02), but lower than the effects in Asia, where the confidence intervals were wider 
(OR: 1.07, 95%CI: 1.01-1.13). Highest NO2 levels were measured in Europe (57.9 μg/m3 ± 8) and 
Asia (51.2 μg/m3 ± 2.4) and lowest levels in North America (42.7 μg/m3 ± 10.8), but in all 
geographical clusters were above mean annual WHO guideline values. A non-linear relationship 
between mean levels and effect estimates was estimated in the meta-regression with stronger 
effects at higher concentrations (Figure 15 SM).  
 
The findings on lagged effects of NO2 exposure are inconsistent. Three studies found 
significant acute effects of same day NO2 exposure with COPD exacerbations (25,40,41) or one to 
two day lagged effects (33,42). Longer three-day lag effects were reported in three large studies 
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(21,27,35), while four smaller studies reported longer lagged effects lasting of up to eight days 
(30,39,43,44). 
 
Effect of O3 
In total, there were 23 studies investigating the effect of O3 on COPD hospital admissions, nine 
were performed in North America, nine in Europe, three in Asia and one in Australia (Figure 7). 
As in the case of NO2, the heterogeneity between studies was large (I2 = 87.23%). Of the 22 
studies, 18 reported a positive effect; however it was significant only in ten studies. Overall, the 
pooled estimates showed that there was a small positive effect of O3 on COPD hospital 
admissions (OR: 1.02, 95% CI: 1.01–1.03). Mean levels of O3 were similar in all geographical 
locations ranging from 43.9 μg/m3 in Asia to 53.6 μg/m3 in North-America and the meta-
regression model estimated a linear relationship with the effects (Figure 16 SM). 
 
The heterogeneity between studies in geographical subgroups remained high. The pooled 
models showed that the strongest effect (OR: 1.04, 95% CI: 1.03-1.05) was estimated for Asian 
countries, while the effects were marginally significant for North America (OR: 1.01, 95% CI: 
1.00-1.02), and insignificant for Europe (OR: 1.01, 95% CI: 0.99-1.04). Contrary to the pooled 
models, the multicity studies found an insignificant effect in North America (21,23) and a 
significant positive effect in Europe (17). There was no evidence of small-study bias.  
 
The effect of seasonality on the association between O3 and COPD-related hospital admissions 
is unclear. One study in Canada (21) estimated that the effect was nearly twice as large during the 
warm season as over the whole year. Contrary, a study in a tropical climate (33) estimated that the 




Risk of bias assessment 
The risk of bias (and the proportion of which had low, unclear or high risk) for the studies 
included in this review are shown in Figure 8. Detailed descriptions for each individual study are 
included in the supplementary materials. 
 
Discussion  
To our knowledge this is the first study to use meta-analytic techniques to pool the effect 
estimates of the associations between COPD admissions with gaseous pollutants (NO2, O3, CO 
and SO2) and particulate matter simultaneously. The models showed suggestive evidence that all 
investigated pollutants may have a small but significant effect on COPD hospital admissions. 
These findings however, come from a relative small number of studies with high heterogeneity 
between them. Geographical clustering of the effects of pollution on COPD hospital admissions 
was evident and reduced heterogeneity significantly.  
 
Particulate Matter 
Previous systematic meta-analyses have focused on the association between COPD 
exacerbations (8,9) with exposure to particulate matter. Zhu and colleagues (11) estimated a 2.7% 
increase for COPD hospital admissions (95% CI: 1.9%-3.6%) for every 10 μg/m3 increase in 
PM10, and reported large heterogeneity in effect estimates from I2 = 83.9% (11) to 79.4% (9). We 
found a marginally significant effect estimate for PM10 (1·01, 95% CI: 1.0-1.02) similar to Song 
et al (9) but smaller than Zhu and colleagues (11). Song and colleagues (9) found that the strength 
of the association of COPD hospital admissions with PM10 varied among geographical locations 
with an effect of 1% in China and Europe but a larger effect of 2% in the United States. We 
estimated a similar effect of 1% in Europe with very little heterogeneity (I2=1.93%); however a 
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smaller effect of 1% in North America, and a larger effect in Asia of 3% (95% CI: 2% to 5%). A 
possible explanation might be that unlike both previous meta-analyses (9,11), we did not include 
studies where asthma was not separated in the diagnosis. Moreover, we found evidence of a non-
linear relationship where higher effects were reported at higher concentrations.  
Only one meta-analysis (45) estimated the association of COPD admissions (excluding asthma) 
with PM2·5 exposure and found a similar association 1.02 (95% CI: 1.01-3.71) to this study (OR: 
1.03, 95% CI: 1.01-1.05). In line with the findings of Atkinson and colleagues (45), we found 
large heterogeneity between studies but no evidence of small-study bias in the effect estimates of 
PM2.5 for COPD hospital admissions.  
 
It is possible that the marginal effect of particulate matter estimated in this and previous meta-
analytic studies might be influenced by small-study bias. Large multicity studies in North 
America and Europe (19–21) failed to detect a significant association between outdoor PM10 
levels and COPD hospital admissions. Similarly, the two multicity studies in North America 
(18,21) did not find a significant association between PM2·5 exposure and COPD hospital 
admissions.  
 
The effect of seasonal variation on the association between PM10 exposure and COPD 
exacerbations is not clear. One multicity study in Italy (19) reported that the association is 7.5 
times stronger in the summer season. A study in Taiwan however (33), found a stronger effect in 
the cool season. A potential explanation for the observed differences might be related to 
behavioural patterns of the population regarding time spent outdoors, which may vary in different 
climates. Another possible explanation in the Asian study may be related to the extensive use of 
mechanical cooling and air filtration in the tropical climate during the warm season that may 
reduce exposure to PM. Similar results have been reported by Janssen et al (46) in the re-analysis 
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of the National Morbidity Mortality Air Pollution study (NMMAPS) in 14 US states, where the 
percentage of households with air handling units had a significant modification effect on COPD 
hospital admissions.  
 
Gaseous pollutants 
The systematic evaluation of the association between COPD exacerbations with gaseous 
pollutants indicates a potential link between CO and SO2 levels with moderate heterogeneity and 
strong geographical clustering. Both pollutants appeared in most studies to have acute effects or 
short lagged effects of up to three and two days respectively on COPD admissions, and a stronger 
effect in the winter season. Marginally stronger effects of CO were estimated in Europe than 
North America. A potential explanation for the difference in effects estimated between Europe 
and North America may be related to different levels of ambient CO concentrations, or the 
methodological design of studies, such as the absence of multi-city investigations in Europe.  
 
The effect estimates of SO2 in each geographical subgroup indicated that the association was 
only significant in Asian countries with stronger effect in the winter season, marginally significant 
in Europe, and insignificant in North America where the majority evidence comes from, possibly 
because SO2 remains a predominant pollutant in developing countries. The only two available 
multi-city studies on the effects of SO2 found contradictive results; one study in Europe reporting 
a marginal positive association (17) and one study in North America (21) reported a negative non-
significant association. A possible explanation is that the chronological difference between these 
two studies reflects differences in outdoor SO2 concentrations.  
 
The associations between NO2 and O3 exposure with COPD hospital admissions is less well 
understood, as the heterogeneity between studies in this review was large. Both pollutants showed 
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marginal associations in Europe and North America, and stronger effects in Asia. Only three 
studies in Asia found an association both with O3 and NO2 (29,33,40). Studies in Europe and 
North America found an association either with NO2 (24,30,35,43) or O3 alone (17,27,39,47,48).  
 
Limitations  
A number of limitations in the methodological design of the studies included in this review do 
not allow establishing a clear link between the effects of environmental pollution on COPD 
exacerbations. Using hospital admissions as an indication of exacerbation is a potential source of 
ecological fallacy, as it ignores individual-level characteristics and assesses health outcomes at 
group level. Relationships at individual level might not reflect group level relationships and vice 
versa. Health-care use in COPD can vary depending on access, and it was not always possible to 
separate emergency from scheduled admissions, adding further uncertainty to the estimation of 
exacerbations.  
 
Although many studies employed both single-pollutant and multi-pollutant models, results 
were included only from single-pollutant models and the findings do not account for any 
covariance between air pollutants (such as NO2 and O3 or NO2 and PM). Other unmeasured 
pollutants in the mixture might also be important in the observed health outcomes (such as 
ultrafine particles). The confounding effects of temperature and humidity add further challenges. 
Although we know that there are seasonal effects on COPD exacerbations in northern and 
southern regions (49), the relationships between temperature and humidity with COPD admissions 




The studies were grouped based in geographical location, which had the potential of reducing 
the heterogeneity of the subgroups, however the small sample size limited the interpretation of the 
results. We used random-effects models, which can account for the heterogeneity between studies 
better than fixed models. While this standardised method may reduce the small-study bias, it 
cannot differentiate multi-city from single-city studies if the standard error is similar. Moreover, 
while the RE pooled models assume a linear relationship between air pollutants and effect 
estimates, we found evidence of a non-linear relationship with higher effects reported at higher 
concentrations for all pollutants apart from O3 an SO2 that exhibited a linear relationship. 
A significant limitation of the studies included the low spatio-temporal resolution of air 
pollution measurements from fixed monitoring stations as a surrogate for personal exposure. 
However, in practise air quality is highly granular and people, particularly those with chronic 
respiratory diseases, may spend a large fraction of their time indoors, where they might be 
exposed to a mixture of emissions from indoor sources. Missing daily monitoring data add further 
uncertainty in the analysis of time-series studies with daily lags in the exposure variable. Rather 
than using fixed site monitors as a proxy for “true” exposures, the development of hybrid models 
that combine pollutant dispersion models with space-time-activity models may prove to be a more 
effective way of examining the effects of personal environmental exposure on health (50).  
 
Conclusions 
A key finding of this review is that the effects of separate pollutants on COPD admissions 
appears to vary across geographical regions. Effects were evident even at concentration below 
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Figure 1: Flow chart of the literature search and screening process. 
 
Figure 2: Pollution levels and summary estimates (95% confidence intervals) for COPD related 
hospital admissions per 10 μg/m3 increase in PM10. 
 
Figure 3: Pollution levels and summary estimates (95% confidence intervals) for COPD related 
hospital admissions per 10 μg/m3 increase in PM2.5.  
 
Figure 4: Pollution levels and summary estimates (95% confidence intervals) for COPD related 
hospital admissions per 1 mg/m3 increase in CO levels.  
 
Figure 5: Pollution levels and summary estimates (95% confidence intervals) for COPD related 
hospital admissions per 10 μg/m3 increase in SO2 levels.  
 
Figure 6: Pollution levels and summary estimates (95% confidence intervals) for COPD hospital 
related admissions per 10 μg/m3 increase in NO2 levels. 
 
Figure 7: Pollution levels and summary estimates (95% confidence intervals) for COPD hospital 
related admissions per 10 μg/m3 increase in O3 levels.  
 









Table 1: Inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria 
• Reports a specific outcome of COPD 
exacerbation defined by hospital or 
emergency department admissions. 
• Recorded by clinician or in hospital 
records using the codes for the 
International Classification of 
Diseases Ninth and Tenth Revisions 
(ICD-9 490-496 excluding 493 for 
asthma; and ICD-10 J44.1-J44.9). 
• Reports a measure of air quality, 
either from a fixed monitoring 
station, indoor environment or 
personal exposure (indoor to be 
analysed separately from outdoor). 
• Reports the findings of a primary 
research study or secondary analysis. 
• Published in English 
• Reported results from single-
pollutant models. 
• Studies of the same author that 
repeat results (the most recent were 
selected). 
• Studies that included asthma (ICD-9 
493) were excluded because of 
clinical and pathological differences 
between COPD and asthma (19). 
• Incorrect outcome: Included other 
respiratory diseases combined with 
COPD in the statistical analysis.  
• Uncertain diagnosis of COPD. 
• Did not report or provide calculable 
Odds Ratio (OR), Relative Risk 
(RR), or Percentage Change (PC) 
and 95% Confidence Intervals (CIs). 
• Poor quality: lacked adjustment for 
potential confounders, missing data, 
inadequate statistical analysis. 
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